• Nem Talált Eredményt

Inhibition of 17α-hydroxylase-c17,20-lyase (p45017α) by steroidal picoline and picolinylidene compounds

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Inhibition of 17α-hydroxylase-c17,20-lyase (p45017α) by steroidal picoline and picolinylidene compounds"

Copied!
1
0
0

Teljes szövegt

(1)

.

INHIBITION OF 17α-HYDROXYLASE-C 17,20 -LYASE (P450 17α ) BY STEROIDAL PICOLINE AND PICOLINYLIDENE COMPOUNDS

Nikoletta Szabó

1

, Jovana Ajduković

2

, Imre Ignáth

1

, Marija Sakač

2

, Evgenija Djurendić

2

, János Gardi

1

, Gábor Mahmoud

1

, Suzana Jovanović-Šanta

2

, Katarina Penov Gaši

2

, Mihály Szécsi

1

1

First Department of Medicine, University of Szeged, Szeged, Hungary

2

Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, Novi Sad, Serbia

INTRODUCTION

17-Hydroxylase-C17,20-lyase (P45017α) is a key regulator enzyme of the androgen biosynthetic pathway that catalyzes both the 17-hydroxylation and the

cleavage of the C17–C20 side-chain of 21-carbon steroids in both the testes and the adrenals. Inhibition of this enzyme can block androgen synthesis in an early step, and may thereby be useful in the treatment of prostatic carcinoma, which is androgen-dependent in the majority of cases. Abiraterone (3β-hydroxy- 17-(pyridyl)-androsta-5,16-diene) and its analogues have been found strong inhibitors of P45017a, suggesting that steroid derivatives with heterocyclic

substituent on the C17 position may possess such potential. Inhibition studies also contribute to the exploration of structural features of the enzyme and help to understand better mechanism of the biotransformation. Experiments using rat tissue preparations are widely acknowledged in vitro tests for the investigation of a presumed P45017a inhibitory activity. Inhibitor complexed X-ray crystal structure of the human enzyme has been determined recently (DeVore NM and Scott EE, Nature 2012;482:116-120.) and displays strong similarity to the predicted 3D model (ModBase) of the rat P45017a.

AIM

• We investigated inhibitory effect Inhibitory effects of twelve novel 17-picolyl and 17- picolinylidene androstene compounds exerted against the 17a-Hydroxylase and the subsequent C17,20-lyase activities of the rat testicular P45017α were investigated.

CONCLUSIONS

• Our results revealed that 17-picolinylidene-androst-4-en-3-one and 17- picolinylidene-androst-4-en-3-one-N-oxide were potent inhibitors of the P45017α. Both compounds exerted similar inhibitory effect against C17,20- lyase activity, IC50 values were found to be 2.5µM and 2.9µM, respectively.

• The 17a-hydroxylase activity was inhibited five times more efficiently by the N-oxide derivative (IC50=1.2µM) than by its unsubstituted 17- picolinylidene counterpart (IC50=5.9µM).

• Further tested compounds did not inhibit enzyme activities substantially.

• Our results provide new data on P45017α inhibition and on modulation of its two distinct activities. Structure-activity relationships give better understanding on the mechanisms of androst-4-en-3,17-dione biosynthesis and testosterone production, as well as findings may contribute to the development of new drug molecules with specific anti- hormonal effect.

Nikoletta Szabó’s work was supported by the Talentum Fund and Centenáriumi Fund of Richter Gedeon Plc., TÁMOP-4.2.2/B-10/1-2010-0012 project , the

Hungary-Serbia IPA Cross-border Co-operation Programme project number HURSB/1002/214/133 RECODAC, and the Provincial Secretariat for Science and Technological Development of the Autonomous Province of Vojvodina grant number 114-451-2713/2012-01

Enzyme activites measured

In vitro radioincubation method for the measurement of C17,20-lyase activity and inhibition

INCUBATION

1 ml, 37 °C, shake in air, 20 min Substrate 1.0 M

No. 1 14C-Prog

No. 2 3H-17OH-Prog Coenzyme 1 mM

NADPH

Extraction

ethyl acetate, carrier

Inhibitor (0-50 μM) Rat testis

homogenate in HEPES buffer pH=7.3

TLC isolation

Product Substrate

C O

C H 3

C O

C H 3

O O

O H

O

O

Progesterone 17-Hydroxy-progesterone 4-en-dione

C17,20-lyase 17α-hydroxylase

O

H

N

O

H

N O

17-picolinylidene-androst- -4-en-3-one

17-picolinylidene-androst- -4-en-3-one-N-oxide

Most important two picolinylidene compounds

No. 1 3H-17OH-Prog and 4-en-dione No. 2 4-en-dione

No. 1 No. 2

RESULTS

Inhibition of 17α-Hydroxylase-C17,20-lyase activities by 17-picolyl and 17- picolinylidene compounds. Relative conversions (control incubation with no inhibition is 100%) measured in the presence of 50 μM concentration of the compound tested. NI: no inhibition.

Ohlase

/

Lyase

Rel. Conv (%)

OHlase

/

Lyase

IC50 (µM)

OHlase

/

Lyase

95 ,0

/

115,2 38,0

/

8,2

/

90,4

/

65,7 49,7

/

13,7

Rel. Conv (%)

/

61,6 %

87,3

/

73,0 5,9

/

2,5

IC50 (µM)

1,2µM

/

2,9µM

O OH OH

HO CH2-Py H Py H Py

D-ring O

A-ring

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

Given the promising biological activities of these compounds against cancer and specific bacterial strains, we have now explored the potential use of the selenoanhydride (SeAnh) 1

The antiproliferative activity of the selected compounds on the A375P melanoma cell line and the kinase inhibitory activity on B-Raf(wt). and

CBT had a positive effect on the tensile strength and elonga- tion at break values of SBR and oSBR compounds, though in oSBR compounds above 20 phr CBT content a setback can be

The inhibitory e ff ect against SIRT6 deacetylation activity of the known SIRT6 modulators and the most potent compounds of this study were confirmed using in vitro immunoblotting

Antioxidant and xanthine oxidase inhibitory studies show that chlorine- and iodine-substituted compounds exhibited greatest bioactivities, with molecular docking simulations

The results suggest that red wines effectively inhibit the formation of amyloid-like fibrils of trypsin and the inhibitory effect is dose-dependent.. The extent of inhibition was

While the AMPAR antagonist GYKI 52466 exerted a reduced inhibitory effect on evoked EFPs in brain slices of seizured group, the effects of the NMDAR antagonist APV mildly

luminescens strains and about their inhibitory effects against Trichoderma species is very important when planning the development of an appropriate control method against